wellrank.ai
Sign In

Wegovy vs Zepbound: which one should I ask for and where do I get either online?

ClaudecomparisonCollected Sep 23, 2026, 11:33 UTC

Verbatim response from Claude

Wegovy vs Zepbound: Quick Comparison

The Drugs

Wegovy (semaglutide)

  • GLP-1 receptor agonist
  • Average weight loss: ~15% of body weight
  • Made by Novo Nordisk
  • Weekly injection

Zepbound (tirzepatide)

  • Dual GLP-1/GIP receptor agonist
  • Average weight loss: ~20-21% of body weight
  • Made by Eli Lilly
  • Weekly injection
  • Generally considered more effective based on clinical trials

Which to Ask For?

Ask about Zepbound first if maximum weight loss is your priority — the SURMOUNT trials showed stronger results than STEP trials for Wegovy.

Consider Wegovy if you have cardiovascular disease history (it has more established heart outcome data).

Where to Get Online (Legitimate Sources)

  • Hims & Hers (hims.com) — offers both, telehealth consultation included
  • Ro Body (ro.co) — popular, straightforward process
  • Found (joinfound.com) — includes coaching support
  • LifeMD — connects you with licensed prescribers

Important Notes

⚠️ You need a prescription — these platforms provide legitimate medical consultations ⚠️ Check your insurance coverage — costs can be $500-$1,300+/month without it ⚠️ Avoid any site that skips a medical consultation

Would you like more detail on any of these?

Brands mentioned in this answer

More Wegovy answers

See all Wegovy rankings and answers →

Is this answer wrong about your brand?

AI engines repeat outdated pricing, wrong ingredients, and misread positioning every day. Tell us what this answer gets wrong and we will include a correction review in your free AI Visibility Audit.

This answer is reproduced verbatim from the engine's API at collection time and may contain errors or outdated claims. It is presented as evidence of what AI engines tell buyers, not as medical or purchasing advice.

Is your brand missing from this answer?

Get your AI Visibility Audit: every buyer intent question you are losing, who wins them, and the sources that decide the answer.